Faron
Pharmaceutical Manufacturing in Finland
Overview
Faron is a clinical stage biopharmaceutical company developing novel treatments for medical conditions with significant unmet needs. Its lead program is bexmarilimab, its investigative precision immunotherapy in Phase I/II development as a novel macrophage checkpoint immunotherapy for patients with hematological malignancies. Bexmarilimab is a novel anti-Clever-1 antibody with the ability to switch immune suppression to immune activation. Faron is based in Turku, Finland and Boston, Massachusetts. Faron is listed on AIM under the ticker ‘FARN’ and Nasdaq First North Growth Market ("Nasdaq First North") under ticker FARON.
Tagline
A CLEVER Approach to Fight Cancer.
EMPLOYEES
11-50 employees
FOUNDED
2007
HQ
Turku
TYPE
Public Company
Location
- Street
- Joukahaisenkatu 6
- City
- Turku
- Region
- —
- Postal code
- 20520
- Country
- Finland
Email patterns
See email patterns for Faron
Address formats, how often each is used and the mail provider.
Start for freeTrade fairs
FAQ
What is the company name?
faron.com is the website of Faron.
What is the industry of the company?
Faron (faron.com) is in the Pharmaceutical Manufacturing industry.
What products and services does the company offer?
Faron (faron.com) lists these specialties: Drug discovery, Drug development, Pharmaceuticals, Novel treatments for medical conditions with significant unmet needs, ARDS, Acute Respiratory Distress Syndrome, Cancer immunotherapy, and biopharmaceutical.
When was the company founded?
Faron (faron.com) was founded in 2007.
How many employees does the company have?
Faron (faron.com) has 11-50 employees.
What is the company type?
The company type of Faron (faron.com) is Public Company.
Where is the company headquartered?
Faron (faron.com) is headquartered in Turku.
What is the address of the company?
The address of Faron (faron.com) is Joukahaisenkatu 6, Turku, 20520, Finland.
What are the social media accounts of the company?
The social media account of Faron (faron.com) is LinkedIn.
Social media